Clinical trials
Enrolling by invitation Observational Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Provincial Hospital | 2 |
| Ain Shams University | 1 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| GrandPharma (China) Co., Ltd. | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| NYU Langone Health | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Seoung Hoon Kim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 10 |
| Fibrosis | 1 |
| Liver Cirrhosis | 1 |
| Liver Diseases | 1 |
| Liver Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.